Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · December 19, 2023

Checkpoint Inhibitor–Associated Autoimmune Diabetes Characterised by C-Peptide Loss and Pancreatic Atrophy

The Journal of Clinical Endocrinology and Metabolism


Additional Info

Disclosure statements are available on the authors' profiles:

The Journal of Clinical Endocrinology and Metabolism
Checkpoint inhibitor associated autoimmune diabetes mellitus is characterised by C-peptide loss and pancreatic atrophy
J. Clin. Endocrinol. Metab. 2023 Nov 24;[EPub Ahead of Print], L Wu, MS Carlino, DA Brown, GV Long, R Clifton-Bligh, R Mellor, K Moore, SC Sasson, AM Menzies, V Tsang, JE Gunton

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading